Experience the Quality With Free NAPLEX Exam Questions That Helps Candidates Pass

Isotretinoin is highly teratogenic. Risk management (e.g., iPLEDGE in the U.S.) requires two negative pregnancy tests before initiation, monthly testing, and the use of two effective forms of contraception (or strict abstinence) during therapy and for a period after discontinuation. Option C captures these critical safeguards, aligning with stringent requirements designed to prevent fetal exposure. Option A is incomplete; while abstinence is an option, pregnancy testing and program compliance are still mandatory. Option B understates contraception requirements (two forms, not one) and still requires two baseline tests. Option D is dangerously incorrect; teratogenicity risk persists throughout early pregnancy exposure, and no “safe” window exists during treatment. Pharmacists must verify program compliance before dispensing, document counseling, and ensure patients understand timelines and acceptable contraceptive methods.

Vincristine is fatal if given intrathecally. To prevent syringe errors, it must always be dispensed in a minibag labeled “IV only”. Methotrexate and cytarabine may be given intrathecally in specific regimens, while cyclophosphamide is systemic. Safe dispensing practices prevent catastrophic errors.

Vaccine potency depends on strict cold-chain control. Digital data loggers with calibrated probes and recorded min/max temperatures enable early detection of excursions and implementation of action plans (quarantine, manufacturer guidance, patient recall if needed). Option A increases selection errors; vaccines require segregation and labeling. Option C is unsafe—pre-drawing increases contamination and dosing errors; most vaccines should be drawn immediately before administration. Option D is inappropriate; visual inspection does not validate potency nor safety beyond labeled expiry. Robust storage/monitoring plus standardized workflows (screening checklists, VIS provision, documentation) enhance safety and compliance.

Amiodarone is associated with pulmonary fibrosis, thyroid dysfunction, hepatotoxicity, and corneal deposits due to iodine content and tissue accumulation. Baseline and periodic chest X-rays and PFTs are recommended. Flecainide and sotalol do not cause pulmonary fibrosis. Diltiazem is a calcium channel blocker, not associated with this effect.

Vincristine must never be given intrathecally, as it causes irreversible neurotoxicity and death. It must be administered IV only, preferably in a minibag to reduce syringe error. Options A, C, and D are incorrect and unsafe. This is a critical safety rule in oncology.